Sarah Jacques

机构：University of Colorado Anschutz Medical Campus, University of Montana · ORCID：0009-0007-2269-4831

发表论文 6 篇 · 总被引 72 次 · h-index 3

代表论文

• Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins (2023 · Nature Nanotechnology · 被引 45)
• Optimized Enzyme-Linked Immunosorbent Assay for Anti-PEG Antibody Detection in Healthy Donors and Patients Treated with PEGylated Liposomal Doxorubicin (2024 · Molecular Pharmaceutics · 被引 14)
• Enhanced immunocompatibility and hemocompatibility of nanomedicines across multiple species using complement pathway inhibitors (2025 · Science Advances · 被引 12)
• How Reproducible Is Feraheme® (Ferumoxytol Injection)? Comparison of Size, Zeta Potential, and Complement Activation of Different Batches over 15 Years (2024 · Journal of Nanotheranostics · 被引 1)
• Bioorthogonal tuning of nanosurface opsonisation via click coupling of a complement fusion protein inhibitor (2026 · Chemical Communications)
• Magnetic Nanoworm-Based Screening of Yeast Library for Anti-PEG Nanobodies (2025 · Molecular Pharmaceutics)